• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHL0500643 硫辛酸分散片 arlipoic acid Tablet Chemical Drugs(3.1) New Drug Application 2005-04-21 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2005-12-06 view
CXHL0502008 复方硫酸氨基葡萄糖胶囊 Capsule Chemical Drugs(3.2) New Drug Application 2005-12-12 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2006-11-06 view
CXHL0502009 复方硫酸氨基葡萄糖片 Tablet Chemical Drugs(3.2) New Drug Application 2005-12-12 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2006-11-06 view
CXHL0502417 复方硫酸氨基葡萄糖分散片 Tablet Chemical Drugs(3.2) New Drug Application 2006-02-24 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2007-04-13 view
CXHL0601166 盐酸左旋多巴甲酯 Melevodopa hydrochloride Active ingredient Chemical Drugs(3.1) New Drug Application 2007-01-10 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2008-09-03 view
CXHL0601167 盐酸左旋多巴甲酯片 Melevodopa hydrochloride Tablet Chemical Drugs(3.1) New Drug Application 2007-01-10 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2008-09-03 view
CXHL0700189 盐酸左旋多巴甲酯 Melevodopa hydrochloride Active ingredient Chemical Drugs(3.1) New Drug Application 2007-08-22 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2008-10-13 view
CXHL0700190 盐酸左旋多巴甲酯片 Melevodopa hydrochloride Tablet Chemical Drugs(3.1) New Drug Application 2007-08-22 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2008-10-13 view
CXHL0700278 复方硫酸氨基葡萄糖咀嚼片 Tablet Chemical Drugs(3.2) New Drug Application 2007-10-22 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2008-07-15 view
CXHL0700532 阿德福韦酯分散片 adefovir dipivoxil Tablet Chemical Drugs(3.1) New Drug Application 2008-02-21 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2009-10-12 view
CXHL0900005 他米巴罗汀 tamibarotene Active ingredient Chemical Drugs(3.1) New Drug Application 2009-02-12 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2010-06-24 view
CXHL0900006 他米巴罗汀片 tamibarotene Tablet Chemical Drugs(3.1) New Drug Application 2009-02-12 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2010-06-24 view
CXL01D08G 盐酸洛美利嗪 Lomerizine Hydrochloride Active ingredient Chemical Drugs(2) New Drug Application 2002-03-18 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2003-10-17 view
CXL01D09G 盐酸洛美利嗪片 Lomerizine Hydrochloride Tablet Chemical Drugs(2) New Drug Application 2002-03-18 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2003-10-17 view
CXL20021100G 佐米曲普坦 zolmitriptan Active ingredient Chemical Drugs(4) New Drug Application 2002-07-10 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2003-12-05 view
CXL20021101G 佐米曲普坦片 zolmitriptan Tablet Chemical Drugs(4) New Drug Application 2002-07-10 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2003-12-05 view
CXL20021102G 氢溴酸西酞普兰 citalopram hydrobromide Active ingredient Chemical Drugs(4) New Drug Application 2002-08-13 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2003-12-05 view
CXL20021103G 氢溴酸西酞普兰片 citalopram hydrobromide Tablet Chemical Drugs(4) New Drug Application 2002-08-13 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Certificate Issued 2003-12-05 view
CXL20021341G 依达拉奉 edaravone Active ingredient Chemical Drugs(2) New Drug Application 2002-12-18 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Approval Completed-Pending Certificated 2003-01-28 view
CXL20021342G 依达拉奉注射液 edaravone Injection Chemical Drugs(2) New Drug Application 2002-12-18 南京威尔曼药物研究所 Nanjing Welman Medicament Research Institute Approval Completed-Pending Certificated 2003-01-28 view